| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/19/2006 | CA2572873A1 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 01/19/2006 | CA2572551A1 Combination of anti-hiv reverse transcriptase and protease inhibitors |
| 01/19/2006 | CA2571739A1 A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| 01/19/2006 | CA2570591A1 Antibiotics containing borinic acid complexes and methods of use |
| 01/19/2006 | CA2569091A1 Modulation of gsk-3.beta. and method of treating proliferative disorders |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616957A1 Vector |
| 01/18/2006 | EP1616954A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 01/18/2006 | EP1616950A1 Peptide having htlv-1-specific ctl-inducing activity |
| 01/18/2006 | EP1616876A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616578A1 Compositions and methods for delivery of genetic material |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616573A2 Adjuvants for use in vaccines |
| 01/18/2006 | EP1616564A2 Manipulation of nitrosative stress for treating microbes and helminths |
| 01/18/2006 | EP1616563A2 Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases |
| 01/18/2006 | EP1615950A2 S. pneumoniae antigens |
| 01/18/2006 | EP1615941A1 Isopropanolate of azithromycin and method of manufacturing |
| 01/18/2006 | EP1615939A1 Sulfoglycolipid antigens, their extraction from mycobacterium tuberculosis, and their use against tuberculosis |
| 01/18/2006 | EP1615917A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity |
| 01/18/2006 | EP1615916A1 Antimicrobial 3.1.0 bicyclohexylphenyl-oxazolidinone derivatives and analogues |
| 01/18/2006 | EP1615660A1 Pharmaceutical composition containing interferon for the treatment of hpv infections |
| 01/18/2006 | EP1615629A1 Peptide deformylase inhibitors |
| 01/18/2006 | EP1615613A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/18/2006 | EP1487968A4 Methods of inducing differentiation of stem cells into a specific cell lineage |
| 01/18/2006 | EP1470138B1 Mmp inhibitors |
| 01/18/2006 | EP1404347B1 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1381601B1 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 01/18/2006 | EP1363612A4 Peptide deformylase inhibitors |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1214064A4 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 01/18/2006 | EP0973727B8 Activated iododerivatives for the treatment of cancer and aids |
| 01/18/2006 | EP0882129B1 Recombinant expression of s-layer proteins |
| 01/18/2006 | CN1723215A Anhydrous crystalline azido cytosine hemisulfate derivative |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723037A Methods and compositions for promoting the maturation of monocytes |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721442A Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/18/2006 | CN1721432A Peptide specifically associated with front surface antigen zone of large protein of human hepatitis B virus surface antigen and uses thereof |
| 01/18/2006 | CN1721427A Novel erythromycin derivatives |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1721387A Traditional Chinese Medicine extract against SARS virus |
| 01/18/2006 | CN1720972A Chinese medicine for treating dermatomycosis and its preparing process |
| 01/18/2006 | CN1720970A Broad spectrumed antiseptic pure Chinese medicine preparation and its preparation method |
| 01/18/2006 | CN1720969A Chinese proprietary medicine |
| 01/18/2006 | CN1720965A Chinese medicinal composition for treating acute icterohepatitis |
| 01/18/2006 | CN1720962A Dripping pills for tonifying kidney and strengthening bone and method for preparing the same |
| 01/18/2006 | CN1720930A Anti-AIDS material drug, tablet, capsule, oral liquid and preparation method thereof |
| 01/18/2006 | CN1720922A Preparation of anti-infection CpG oligonucleotide DNA preparation and its application technology |
| 01/18/2006 | CN1720915A Anti-beta-lactamase antibiotic composite preparation |
| 01/18/2006 | CN1720914A Anti-beta-lactamase antibiotic composite preparation |
| 01/18/2006 | CN1720913A Water-soluble triazole fungicide |
| 01/18/2006 | CN1720909A Application of Cytospora bacterin B in preparation of antifundal medicine |
| 01/18/2006 | CN1237185C SARS coronavirus 3Cl protease two-dimensional model and medicine preventing SARS |
| 01/18/2006 | CN1237184C Target for medicine against SARS-Cov and medicine screening method and medicine against SARS |
| 01/18/2006 | CN1237073C Gene configuration, preparing process and usage of antibacterial peptide |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237056C Oxazolidone compound, preparing method and use thereof |
| 01/18/2006 | CN1236831C Compositions for protein delivery via the pulmonary route |
| 01/18/2006 | CN1236818C Caprine arthritis-encephalitis virus provided immunoprotection against HIV-1 infection |
| 01/18/2006 | CN1236814C Faluopeinan medicine composition containing glutathione |
| 01/18/2006 | CN1236813C Self-emulsifying compositions for drugs poorly soluble in water |
| 01/18/2006 | CN1236808C Medicine for treating hepatitis B |
| 01/18/2006 | CN1236805C Wanpi ointment for treating skin disease |
| 01/18/2006 | CN1236798C External medicine for treating bone tuberculosis |
| 01/18/2006 | CN1236789C Medicine for treating mycotic infection beriberi |
| 01/18/2006 | CN1236788C Medicine for curing upper respiratory tract infection and preparation method of its granule preparation |
| 01/18/2006 | CN1236786C Ointment with functions of detoxification, relieving inflammation and stopping pain |
| 01/18/2006 | CN1236777C Stabilized brivudine topical formulations containing metal oxide pigments |
| 01/18/2006 | CN1236772C Specific medicinal composition for treating hepatitis B |
| 01/18/2006 | CN1236769C Inhibitor for inhibiting cell adhesion |
| 01/18/2006 | CN1236764C Method for preparing a composition |
| 01/17/2006 | US6987176 Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization |
| 01/17/2006 | US6987175 Slurrying in aqueous solution; antibiotics |
| 01/17/2006 | US6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 01/17/2006 | US6987126 Neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987115 Treating bacterial infections with a 1,2,3,4-tetrahydrobeta-carbolin-2-yl-alkyl-1-one; chemical intermediates, amidation |
| 01/17/2006 | US6987114 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987109 Solubilized topoisomerase poison agents |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | US6987102 Methods to mobilize progenitor/stem cells |
| 01/17/2006 | US6987093 Single dose azithromycin |
| 01/17/2006 | US6987092 Indigoid bisindole derivatives |
| 01/17/2006 | US6986908 Delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite |
| 01/17/2006 | US6986900 biocompatible implants for delivery of pharmaceutically active agents to the posterior segment of the eye; having a scleral surface, an orbital surface, an injection port on the orbital surface, and a fluid conducting passageway |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2351829C Macrolide antibiotics |
| 01/17/2006 | CA2239520C Use of 1-hydroxy-2-pyridones for treating mucosal disorders which are difficult to treat |
| 01/17/2006 | CA2086425C Fibroblast growth factor receptors |
| 01/12/2006 | WO2006003518A2 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 01/12/2006 | WO2006003492A2 Compositions and methods for treating pathological infections |
| 01/12/2006 | WO2006002927A2 Medium chain fatty acids applicable as anti-microbial agents |
| 01/12/2006 | WO2005118613A3 Antibacterial amide macrocycles |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004062597A3 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |